# US 2021/0275631 A1 · Anticancer composition comprising cervical cancer-derived autocrine motility factor as effective component

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275631 A1
- Document ID: US20210275631A1
- Status: Published application
- Kind: A1
- Application number: 16/621,007
- Filed: 2018-06-04
- Published: 2021-09-09
- Earliest claimed: 2017-06-14
- Assignees: Daegu Catholic University Industry Academic Cooperation Foundation
- Applicants: Daegu Catholic University Industry Academic Cooperation Foundation
- Inventors: Hee Sung PARK
- Web page: https://patentgrep.com/patent/US20210275631A1

## CPC

- A61K 38/1709: {from mammals}
- A61K 9/16: Agglomerates; Granulates; Microbeadlets {; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction (A61K9/20 takes precedence if the final form is a tablet; microspheres with drug-free outer coating, microcapsules A61K9/50; mixture of different granules, microcapsules, (coated) microparticles A61K9/5084; nanoparticles A61K9/51)}
- A61K 9/20: Pills, tablets, {discs, rods (A61K9/0004, A61K9/0007, A61K9/0056, A61K9/0065 take precedence; for reconstitution of a drink A61K9/0095)}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 38/17: from animals; from humans {(enzyme inhibitors A61K38/005)}
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An anticancer composition includes cervical cancer-derived autocrine motility factor (AMF) as an effective component. The cervical cancer-derived AMF has an excellent effect of inhibiting the proliferation of liver cancer, pancreatic cancer, breast cancer, lung cancer, prostate cancer, and colon cancer, and inducing cell death. The composition can be used as an anticancer therapeutic agent.

## Claims

### Claim 1

A pharmaceutical composition comprising cervical cancer-derived autocrine motility factor (AMF) with the amino acid sequence represented by SEQ ID NO: 1 as an effective component.

### Claim at position 2

2-5. (canceled)

### Claim 6 (depends on 1)

The pharmaceutical composition according to claim 1, wherein the pharmaceutical composition is prepared in the form of a capsule, a powder, a granule, a tablet, a suspension, an emulsion, a syrup, an aerosol, a formulation for external application, a suppository, or a sterile injection solution.

### Claim 7 (depends on 1)

A method for inhibiting proliferation of cancer cells or promoting death of the cancer cells, the method comprising administering the pharmaceutical composition according to claim 1 to a subject having the cancer cells.

### Claim 8 (depends on 7)

The method of claim 7, wherein the cancer cells are cells of at least one cancer selected from the group consisting of liver cancer, pancreatic cancer, breast cancer, lung cancer, prostate cancer, and colon cancer.

### Claim 9 (depends on 7)

The method of claim 7, wherein the method is for inhibiting the proliferation of the cancer cells.

### Claim 10 (depends on 7)

The method of claim 7, wherein the method is for promoting the death of the cancer cells.

### Claim 11 (depends on 7)

The method of claim 7, wherein the pharmaceutical composition is prepared in the form of a capsule, a powder, a granule, a tablet, a suspension, an emulsion, a syrup, an aerosol, a formulation for external application, a suppository, or a sterile injection solution.

### Claim 12 (depends on 7)

The method of claim 7, wherein the subject is a human.

### Claim 13 (depends on 7)

The method of claim 7, wherein the subject is a mammal other than human.

### Claim 14

A method of treating cancer in a subject, comprising administering to the subject a composition comprising a cervical cancer-derived autocrine motility factor (AMF) with SEQ ID NO: 1.

### Claim 15 (depends on 14)

The method of claim 14, wherein the cancer is selected from the group consisting of liver cancer, pancreatic cancer, breast cancer, lung cancer, prostate cancer, colon cancer, and a combination thereof.

### Claim 16 (depends on 14)

The method of claim 14, wherein the composition is prepared in the form of a capsule, a powder, a granule, a tablet, a suspension, an emulsion, a syrup, an aerosol, a formulation for external application, a suppository, or a sterile injection solution.

### Claim 17 (depends on 14)

The method of claim 14, wherein the subject is a human.

### Claim 18 (depends on 14)

The method of claim 14, wherein the subject is a mammal other than human.
